MAPT and Alzheimer disease: Indeed, high IL-1β levels occurred in AD patients and in mild cognitive impaired subjects [107,108], and activated microglia and astrocytes were recently correlated with the levels of hippocampal Aβ and p-tau, and the severity of AD pathology in 3xTg-AD mice [40].